pk 11195 has been researched along with Depressive Disorder in 3 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PK 11195 is a selective ligand for the peripheral-type benzodiazepine binding sites which exhibits anti-conflict activity in animals." | 1.28 | Pilot study of PK 11195, a selective ligand for the peripheral-type benzodiazepine binding sites, in inpatients with anxious or depressive symptomatology. ( Ansseau, M; Cerfontaine, JL; Papart, P; von Frenckell, R, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudryashov, NV | 1 |
| Kalinina, TS | 1 |
| Shimshirt, AA | 1 |
| Korolev, AO | 1 |
| Volkova, AV | 1 |
| Voronina, TA | 1 |
| Marazziti, D | 1 |
| Dell'Osso, B | 1 |
| Baroni, S | 1 |
| Masala, I | 1 |
| Di Nasso, E | 1 |
| Giannaccini, G | 1 |
| Conti, L | 1 |
| Ansseau, M | 1 |
| von Frenckell, R | 1 |
| Cerfontaine, JL | 1 |
| Papart, P | 1 |
3 other studies available for pk 11195 and Depressive Disorder
| Article | Year |
|---|---|
Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; | 2018 |
Decreased density of peripheral benzodiazepine receptors in psychiatric patients after a suicide attempt.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain; Depressive Disorder; Female; Hormones; Humans; Isoq | 2005 |
Pilot study of PK 11195, a selective ligand for the peripheral-type benzodiazepine binding sites, in inpatients with anxious or depressive symptomatology.
Topics: Adolescent; Adult; Anxiety Disorders; Depressive Disorder; Female; Humans; Isoquinolines; Ligands; M | 1991 |